Compounds > levodopa
Page last updated: 2024-08-17

levodopa and vilazodone hydrochloride

levodopa has been researched along with vilazodone hydrochloride in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Avnor, Y; Bishop, C; Chambers, NE; Conti, MM; Gross, L; Lanza, K; Meadows, SM; Ostock, CY1
Jenner, P1
Altwal, F; Moon, C; Steiner, H; West, AR1
Bishop, C; Budrow, C; Centner, A; Cohen, SR; Coyle, M; Glinski, J; Lipari, N; Manfredsson, FP; Smith, S; Terry, ML; Wheelis, E1

Other Studies

4 other study(ies) available for levodopa and vilazodone hydrochloride

ArticleYear
Diverse serotonin actions of vilazodone reduce l-3,4-dihidroxyphenylalanine-induced dyskinesia in hemi-parkinsonian rats.
    Movement disorders : official journal of the Movement Disorder Society, 2018, Volume: 33, Issue:11

    Topics: Animals; Antiparkinson Agents; Disease Models, Animal; Dynorphins; Dyskinesia, Drug-Induced; Enkephalins; Gene Expression Regulation; Levodopa; Male; Oxidopamine; Parkinsonian Disorders; Piperazines; Protein Precursors; Proto-Oncogene Proteins c-fos; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Time Factors; Vilazodone Hydrochloride

2018
The treatment of levodopa-induced dyskinesias: Surfing the serotoninergic wave.
    Movement disorders : official journal of the Movement Disorder Society, 2018, Volume: 33, Issue:11

    Topics: Animals; Dyskinesia, Drug-Induced; Dyskinesias; Levodopa; Rats; Serotonin; Vilazodone Hydrochloride

2018
The Multimodal Serotonergic Agent Vilazodone Inhibits L-DOPA-Induced Gene Regulation in Striatal Projection Neurons and Associated Dyskinesia in an Animal Model of Parkinson's Disease.
    Cells, 2020, 10-09, Volume: 9, Issue:10

    Topics: Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dyskinesias; Gene Expression Regulation; Levodopa; Male; Neurons; Parkinson Disease; Rats; Rats, Sprague-Dawley; Serotonin; Vilazodone Hydrochloride

2020
The multimodal serotonin compound Vilazodone alone, but not combined with the glutamate antagonist Amantadine, reduces l-DOPA-induced dyskinesia in hemiparkinsonian rats.
    Pharmacology, biochemistry, and behavior, 2022, Volume: 217

    Topics: Amantadine; Animals; Antiparkinson Agents; Disease Models, Animal; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Humans; Levodopa; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Serotonin; Vilazodone Hydrochloride

2022